187 related articles for article (PubMed ID: 28871393)
1. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
[TBL] [Abstract][Full Text] [Related]
2. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
[TBL] [Abstract][Full Text] [Related]
3. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
4. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
[TBL] [Abstract][Full Text] [Related]
5. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
Siedek F; Grundmann F; Weiss K; Pinto Dos Santos D; Arjune S; Haneder S; Persigehl T; Müller RU; Baessler B
Invest Radiol; 2020 Apr; 55(4):217-225. PubMed ID: 31876626
[TBL] [Abstract][Full Text] [Related]
8. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
[TBL] [Abstract][Full Text] [Related]
9. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
10. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
12. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
[TBL] [Abstract][Full Text] [Related]
13. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
Bae KT; Tao C; Zhu F; Bost JE; Chapman AB; Grantham JJ; Torres VE; Guay-Woodford LM; Meyers CM; Bennett WM;
Clin J Am Soc Nephrol; 2009 Apr; 4(4):719-25. PubMed ID: 19339416
[TBL] [Abstract][Full Text] [Related]
14. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
[TBL] [Abstract][Full Text] [Related]
15. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
[TBL] [Abstract][Full Text] [Related]
17. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
[TBL] [Abstract][Full Text] [Related]
18. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB;
Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764
[TBL] [Abstract][Full Text] [Related]
19. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
20. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
